Rebecca Whitney - ZimVie Senior Spine
| ZIMV Stock | USD 13.74 0.25 1.85% |
Executive
Rebecca Whitney is Senior Spine of ZimVie Inc
| Age | 47 |
| Address | 4555 Riverside Drive, Palm Beach Gardens, FL, United States, 33410 |
| Phone | 303 443 7500 |
| Web | https://www.zimvie.com |
Rebecca Whitney Latest Insider Activity
Tracking and analyzing the buying and selling activities of Rebecca Whitney against ZimVie stock is an integral part of due diligence when investing in ZimVie. Rebecca Whitney insider activity provides valuable insight into whether ZimVie is net buyers or sellers over its current business cycle. Note, ZimVie insiders must abide by specific rules, including filing SEC forms every time they buy or sell ZimVie'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Rebecca Whitney over six months ago Disposition of 2783 shares by Rebecca Whitney of ZimVie at 16.41 subject to Rule 16b-3 | ||
Rebecca Whitney over six months ago Disposition of 9677 shares by Rebecca Whitney of ZimVie subject to Rule 16b-3 | ||
Rebecca Whitney over six months ago Disposition of 4163 shares by Rebecca Whitney of ZimVie subject to Rule 16b-3 |
ZimVie Management Efficiency
Return On Tangible Assets is likely to climb to -0.45 in 2024. Return On Capital Employed is likely to drop to -0.03 in 2024. At this time, ZimVie's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 981.2 M in 2024, whereas Other Current Assets are likely to drop slightly above 142.4 M in 2024. ZimVie's management efficiency ratios could be used to measure how well ZimVie manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Matthew Link | Sight Sciences | 49 | |
| Jrme Erath | Pulmonx Corp | N/A | |
| Tonya SPHR | CVRx Inc | 52 | |
| Paul Pignato | CVRx Inc | N/A | |
| Hollie Foust | CONMED | N/A | |
| Kevin Smith | Inogen Inc | 53 | |
| Cathy ORourke | Smith Nephew SNATS | 46 | |
| Dragana Bunjevac | Stryker | N/A | |
| Andrew Swift | Smith Nephew SNATS | N/A | |
| Kelley Nicholas | Neuropace | N/A | |
| Anthony Recupero | Si Bone | 65 | |
| John Manders | SurModics | 43 | |
| MBA MD | Inogen Inc | 51 | |
| Andrew Xilas | STERIS plc | 59 | |
| Gordon JD | SurModics | 60 | |
| Roberto Donadello | Orthofix Medical | N/A | |
| Mike Panos | Stryker | N/A | |
| Lucas Vitale | Orthofix Medical | 47 | |
| Daniel Cher | Si Bone | 59 | |
| Tom Huang | Sight Sciences | N/A | |
| Joe Metzger | Smith Nephew SNATS | N/A | |
Management Performance
| Return On Equity | -0.0855 | ||||
| Return On Asset | -0.005 |
ZimVie Inc Leadership Team
Elected by the shareholders, the ZimVie's board of directors comprises two types of representatives: ZimVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ZimVie. The board's role is to monitor ZimVie's management team and ensure that shareholders' interests are well served. ZimVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ZimVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Indraneel Kanaglekar, Senior Officer | ||
| Benjamin Hutson, VP Operations | ||
| Steve Rondeau, Senior Officer | ||
| Vafa Jamali, CEO President | ||
| Michael Minette, Sr Devel | ||
| Ann Vu, Quality Affairs | ||
| Rebecca Whitney, Senior Spine | ||
| Sandra Schneider, Chief Officer | ||
| Laura Driscoll, Vice Communications | ||
| Richard Heppenstall, CFO VP | ||
| Heather Kidwell, Chief VP |
ZimVie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ZimVie a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0855 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.77) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 539.7 M | ||||
| Shares Outstanding | 27.6 M | ||||
| Shares Owned By Insiders | 1.93 % | ||||
| Shares Owned By Institutions | 91.93 % | ||||
| Number Of Shares Shorted | 379.08 K | ||||
| Price To Book | 0.92 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ZimVie Stock Analysis
When running ZimVie's price analysis, check to measure ZimVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZimVie is operating at the current time. Most of ZimVie's value examination focuses on studying past and present price action to predict the probability of ZimVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZimVie's price. Additionally, you may evaluate how the addition of ZimVie to your portfolios can decrease your overall portfolio volatility.